Home Categories API HydralazineHCl
A7736758

HydralazineHCl , 2mMinWater , 304-20-1

Synonym(s):
1-Hydrazinophthalazine hydrochloride;Hydralazine hydrochloride

CAS NO.:304-20-1

Empirical Formula: C8H9ClN4

Molecular Weight: 196.64

MDL number: MFCD00135998

EINECS: 206-151-0

Pack Size Price Stock Quantity
1ml RMB159.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 273°C
Boiling point: 322.13°C (rough estimate)
Density  1.2961 (rough estimate)
refractive index  1.6110 (estimate)
storage temp.  2-8°C
solubility  Soluble in water, slightly soluble in ethanol (96 per cent), very slightly soluble in methylene chloride
form  Solid
color  White to Almost white
PH pH (20g/l, 25℃) : 3.5~4.5
Water Solubility  Soluble in water. Slightly soluble in diethyl ether and alcohol.
Merck  14,4763
BRN  3568329
BCS Class 3
Stability: Stable. Incompatible with strong oxidizing agents.
InChIKey ZUXNZUWOTSUBMN-UHFFFAOYSA-N
CAS DataBase Reference 304-20-1(CAS DataBase Reference)
EPA Substance Registry System 1(2H)-Phthalazinone, hydrazone, monohydrochloride (304-20-1)

Description and Uses

Hydralazine is an orally bioavailable vasodilator and antihypertensive agent. It decreases DNA methylation in Jurkat cells at a concentration of 10 μM and inhibits extracellular and intracellular production of reactive oxygen species (ROS) in rat macrophages activated by phorbol 12-myristate 13-acetate (PMA; ) at a concentration of 100 μM. Hydralazine (100 μM) also decreases nitric oxide production and mRNA expression of inducible nitric oxide synthase (iNOS) in rat macrophages activated by LPS (Item Nos. 19660| 19661| 19662) and interferon-γ (IFN-γ). It reduces contraction of rat aortic arterial strips induced by potassium and norepinephrine (; IC50s = 2.2 and 3.06 mM, respectively). Hydralazine (2.6 mg/kg) lowers mean arterial blood pressure (MAP) by 41.76% in conscious rats. Formulations containing hydralazine have been used in the treatment of high blood pressure and heart failure.

Hydralazine is a non-nucleoside analog that inhibits DNA methylation and reactivates the expression of tumor suppressor genes. Non-selective MAO-A/B inhibitor; semicarbazide-sensitive amine oxidase inhibitor. Antihypertensive.

Safety

Symbol(GHS) 
GHS06
Signal word  Danger
Hazard statements  H301-H315-H319-H335
Precautionary statements  P301+P330+P331+P310-P305+P351+P338
Hazard Codes  Xn
Risk Statements  22-36/37/38
Safety Statements  26-36/37/39-45
RIDADR  UN 2811 6.1/PG 3
WGK Germany  3
RTECS  TH9000000
TSCA  Yes
HazardClass  6.1
PackingGroup  III
HS Code  29339900
Hazardous Substances Data 304-20-1(Hazardous Substances Data)
Toxicity LD50 oral in rat: 280mg/kg

RELATED PRODUCTS